Investment Firm
Overview
DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.
Dec 22, 2015
Pre Seed
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
Accelerate Long Island |
DepYmed raised $100000 on 2015-12-22 in Pre Seed Round
DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 26, 2016 | Series A - DepYmed | 2 | - | 2.0M |
Dec 22, 2015 | Pre Seed Round - DepYmed | 2 | - | 100.0K |
Apr 13, 2021 | Venture Round - DepYmed | 1 | - | 8.3M |
Mar 06, 2024 | Venture Round - DepYmed | - | 500.0K |
Recent Activity
There is no recent news or activity for this profile.